Related Experiment Videos
Peripheral opioid analgesia.
1Department of Anesthesiology and Critical Care Medicine, Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany. wiebke.janson@medizin.fu-berlin.de
Current Pharmaceutical Biotechnology
|October 8, 2003
Summary
Opioids can reduce pain in the body's extremities, not just the brain. This peripheral pain relief, especially during inflammation, offers new targets for pain medications with fewer side effects.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Opioid receptors were traditionally believed to function solely within the central nervous system.
- Recent research indicates the presence and function of opioid receptors in the peripheral nervous system.
- Peripheral opioid analgesia is particularly evident in inflammatory pain conditions.
Purpose of the Study:
- To explore the role of peripheral opioid systems in pain management.
- To investigate the mechanisms underlying opioid receptor and peptide localization in inflamed tissues.
- To identify novel therapeutic strategies for peripheral analgesia.
Main Methods:
- Investigating the transport of opioid receptors to peripheral nerve endings during inflammation.
- Examining the accumulation and release of endogenous opioid peptides from immune cells in inflamed tissues.
- Analyzing the interaction between released opioid peptides and peripheral opioid receptors.
Main Results:
- Opioid receptors are translocated to peripheral sensory nerve endings during inflammation.
- Immune cells in inflamed areas release endogenous opioid peptides.
- These peptides interact with peripheral opioid receptors to produce local analgesia.
Conclusions:
- Peripheral opioid systems play a significant role in modulating pain, especially during inflammation.
- The localization of opioid receptors and release of endogenous opioids in the periphery present new therapeutic targets.
- Development of peripherally acting analgesics could offer effective pain relief with reduced central nervous system side effects.